Suchergebnisse - "Schleiff, Mary A"

PubPharm (11)

1

The role of cytochrome P450 3A4-mediated metabolism in sorafenib and lapatinib hepatotoxicity

enthalten in: Livers | 2023

von McGill, M. | Kaufman, Y. | LoBianco, F. | +3

2

Similar 5F-APINACA Metabolism between CD-1 Mouse and Human Liver Microsomes Involves Different P450 Cytochromes

enthalten in: Metabolites | 2022

von Crosby, S. | Ahmed, I. | Osborn, L. | +7

3

4-Methyl-1,2,3-Triazoles as N-Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Improved Selectivity

enthalten in: Journal of medicinal chemistry | 2021

von Cui, H. | Carlson, A. | Schleiff, M. | +11

4

Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors

enthalten in: Metabolites | 2021

von Flynn, N. | Ward, M. | Schleiff, M. | +6

5

International Society for the Study of Xenobiotics (ISSX) New Investigator Group Committee 2019-2020 concluding remarks

enthalten in: Drug metabolism reviews | 2021

von Schleiff, M. | Sodhi, J.

6

Recent developments in predicting CYP-independent metabolism

enthalten in: Drug metabolism reviews | 2021

von Dhuria, N. | Haro, B. | Kapadia, A. | +5

7

Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam

enthalten in: Toxicology letters | 2021

von Barnette, D. | Schleiff, M. | Datta, A. | +3

8

International Society for the Study of Xenobiotics (ISSX) New Investigator Group Committee 2019–2020 concluding remarks

enthalten in: Drug metabolism reviews | 2021

von Schleiff, M. | Sodhi, J.

9

Recent developments in predicting CYP-independent metabolism

enthalten in: Drug metabolism reviews | 2021

von Dhuria, N. | Haro, B. | Kapadia, A. | +5

10

Significance of Competing Metabolic Pathways for 5F-APINACA Based on Quantitative Kinetics

enthalten in: Molecules (Basel, Switzerland) | 2020

von Pinson, A. | Pouncey, D. | Schleiff, M. | +5